Chronic Lymphoproliferative Leukemia (CLL)
Poseidon

Click on Product Name for more information
Click on Catalog# for Application Manual

Product Name Color Catalog#
ON= Oncology probes 10 test, ready-to-use format

CLL Related Probes

ON DLEU (13q14) / 13qter red/green KBI-10102
ON ATM (11q22) / SE 11 red/green KBI-10103
ON GLI (12q13) / SE 12 red/green KBI-10104
ON 6q21 / SE 6 red/green KBI-10105
ON C-MYC (8q24) / SE 8 red/green KBI-10106
ON ATM (11q22) / GLI (12q13) red/green KBI-10108
ON 6q21 / MYC (8q24) red/green KBI-10109
ON hTERC (3q26) / 3q11 control red/green KBI-10110
ON p53 (17p13) / SE 17 red/green KBI-10112
ON  DLEU (13q14) / p53 (17p13) red/green KBI-10113
ON p53 (17p13) / ATM (11q22) red/green KBI-10114

 

Poseidon

Click on Product Name for more information
Click on Catalog# for Application Manual

Product Name Color Catalog#
ON= Oncology probes 10 test, ready-to-use format

CLL Related Probes

ON DLEU (13q14) / 13qter red/green KBI-10102
ON ATM (11q22) / SE 11 red/green KBI-10103
ON GLI (12q13) / SE 12 red/green KBI-10104
ON 6q21 / SE 6 red/green KBI-10105
ON C-MYC (8q24) / SE 8 red/green KBI-10106
ON ATM (11q22) / GLI (12q13) red/green KBI-10108
ON 6q21 / MYC (8q24) red/green KBI-10109
ON hTERC (3q26) / 3q11 control red/green KBI-10110
ON p53 (17p13) / SE 17 red/green KBI-10112
ON  DLEU (13q14) / p53 (17p13) red/green KBI-10113
ON p53 (17p13) / ATM (11q22) red/green KBI-10114

 

   
Chronic Lymphoproliferative Leukemia (CLL) Minimize

CLL accounts for about 30% of all leukemias in Europe and the USA. Distinct clonal chromosomal abnormalities can be identified in up to 90% of CLL cases of the B-cell lineage. By FISH the most common chromosomal changes in CLL and their frequencies have been identified as shown in the table below.

Del(13q14) 55%
Del(11q) 18%
Trisomy 12q 16%
Del(17p) 7%
Del(6q) 6%
Trisomy 8q 5%
t(14q32) 4%
Trisomy 3q 3%

CLL probe combinations

Most of the CLL probes are also available as combinations covering two critical loci in one hybridization. This is of particular interest if patient material is limited. The disadvantage is that no internal control is added.

[Back to top]

CLL accounts for about 30% of all leukemias in Europe and the USA. Distinct clonal chromosomal abnormalities can be identified in up to 90% of CLL cases of the B-cell lineage. By FISH the most common chromosomal changes in CLL and their frequencies have been identified as shown in the table below.

Del(13q14) 55%
Del(11q) 18%
Trisomy 12q 16%
Del(17p) 7%
Del(6q) 6%
Trisomy 8q 5%
t(14q32) 4%
Trisomy 3q 3%

CLL probe combinations

Most of the CLL probes are also available as combinations covering two critical loci in one hybridization. This is of particular interest if patient material is limited. The disadvantage is that no internal control is added.

[Back to top]